Even consciousness could reveal its secrets someday with this realistic simulation, researchers hope. It will not only ...

Scientists have achieved a feat once believed impossible, constructing the largest functional map of a brain to date, which they believe could eventually lead to the discovery of medications for ...

A long-term study has identified a potential biomarker that could help detect which patients are progressing toward more severe forms of multiple sclerosis.

CCN1 is a key factor for stabilizing brain circuits in adulthood, offering a therapeutic target for conditions, such as Alzheimer's and PTSD.

Myelin loss disrupts the coordination of signals between brain regions, impairing the accurate processing of information, researchers found.

For more than 100 years, Alzheimer’s disease has been treated as a one‑way descent, a diagnosis that could be delayed at best ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.

Researchers at the Jan and Dan Duncan Neurological Research Institute (NRI) at Texas Children’s Hospital and Baylor College of Medicine recently made an important advance in neurodegenerative disease ...

Scientists created the largest functional map of a brain to date using a piece of a mouse's brain. The map details the wiring that connects neurons, offering insight into brain function and ...